Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Merck & Co., Inc.

3 Pharma Stocks Providing Consistent Gains for Investors

The pharmaceutical industry is anticipated to be bolstered due to the increasing demand for chronic disease management and the rising requirements of an aging demographic. Given the industry’s solid prospects, investors could buy quality pharma stocks Eton Pharmaceuticals (ETON), Ipsen S.A. (IPSEY), and Merck & Co. (MRK) for consistent gains.…

StockNews.com

Merck & Co. (MRK) Q3 Earnings Assessment: Is the Pharma Stock a Buy or Sell?

In the wake of Merck & Co.'s (MRK) better-than-expected fiscal third-quarter showing and the enigmatic potential hinted at by its clinical successes, is this pharmaceutical powerhouse a hidden gem for investors? Let's find out.

StockNews.com

Prescribe to Profits With These 3 Pharma Stocks

The pharma industry looks well-positioned for solid growth in the long term amid the rising incidence of chronic illnesses and technological advancements. So, quality pharma stocks, Eli Lilly and Company (LLY), Merck & Co. (MRK), and Teva Pharmaceutical (TEVA) could be profitable investments. Read on.

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

1 Pharma Stock You'll Regret Not Buying Earlier

The long-term prospects of Merck (MRK) look bright due to its latest acquisitions and solid drug pipeline. Therefore, investing in this stock could help generate substantial returns in the long run. Keep reading….

StockNews.com

3 Colossal Stocks to Buy Hand Over Fist Right Now

High-profile bank failures and stubbornly high inflation have heightened volatility in the stock market lately. Regardless of uncertain macroeconomic conditions, colossal stocks Visa (V), Merck (MRK), and Salesforce (CRM) could be ideal buys for market-beating returns. Continue reading….

StockNews.com

3 Large-Cap Stocks to Buy for the Perfect Portfolio in 2023

While the easing inflation and strong labor market have been boosting consumer confidence, uncertainties remain. Moreover, the Fed’s interest rate hikes might continue longer than many think. Therefore, fundamentally sound large-cap stocks, Visa (V), Eli Lilly (LLY), and Merck & Co (MRK), could be ideal buys to navigate the economic…

StockNews.com

3 Stocks for Long-Term Investors to Buy in 2023

As inflation shows signs of cooling, the Fed has significantly slowed its aggressive rate hike policy. Moreover, given a tight labor market, experts believe the economy might avoid a recession. Amid the rising optimism, we think quality stocks Merck (MRK), PepsiCo (PEP), and Limbach (LMB) are ideal buys for long-term…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

3 Stocks It Is Time to Buy Now

Although headline inflation has slowed, the Fed will likely keep raising interest rates to attain its 2% target. However, a potential slowdown in monetary policy tightening is opening the path for quality stocks to recover. Therefore, investors should consider buying fundamentally sound stocks Merck & Co. (MRK), Novartis (NVS), and…

StockNews.com

3 Stocks to Help Protect Your Portfolio Through 2023

With the Fed likely to go ahead with its interest rate hikes this year, the market will likely remain under pressure. Given the foreseen volatility in the stock market, investors might consider investing in stable and dividend-paying stocks Merck & Co. (MRK), Elevance Health (ELV), and Waste Management (WM) to…

StockNews.com

1 Pharma Stock That Could Head Even Higher Next Year

Pharma company Merck & Co. (MRK) is attempting to broaden its portfolio through collaborations and acquisitions. The company looks poised for growth in 2023. So, the stock might be a solid buy now. Read on….

StockNews.com

New to Investing? Give These 2 Robust Stocks a Try

Despite the recent wild swings in the stock market, experts believe stocks to stabilize next year. However, as uncertainties remain, new investors should consider investing in stocks that offer compelling yields, such as Merck & Co (MRK) and Verizon Communications (VZ). Keep reading….

StockNews.com

Is Merck & Co. Stock Worth Buying Before the End of 2022?

Healthcare company Merck & Co. (MRK) is set to acquire Imago BioSciences (IMGO) for more than $1 billion. The stock has gained more than 40% this year. However, given the macroeconomic headwinds, would it be wise to buy the stock now? Read on to find out….

StockNews.com

3 Stocks Insiders Can’t Stop Buying This Month

After signs of cooling inflation, investors are hopeful that the Fed will slow its rate hikes over the coming months. With surging optimism, fundamentally strong stocks Merck (MRK), Coca-Cola (KO), and Verizon (VZ), which have seen increased insider buying, might be ideal investments now. Continue reading.

StockNews.com

4 Stocks to Buy That Have Caught Wall Street's Attention

With strong indications of slowing interest rate hikes by the Fed poised to feed the stock market rally, it could be wise to invest in Merck (MRK), AT&T (T), Mosaic (MOS), and Photronics (PLAB), which are in vogue on Wall Street. Continue reading….

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

2 Stocks the Smart Money on Wall Street Owns the Majority Right Now

The Federal Reserve is expected to lower the pace of its rate hikes from next month. However, concerns about an economic slowdown are still evident. Hence, this might be the time to follow the smart money and buy Merck (MRK) and Yelp (YELP). Institutions own the majority of shares of…

StockNews.com

2 Stocks That Are Too Good of Buying Opportunities to Ignore

The latest CPI report shows signs of a cooling down inflation. On the other hand, the healthcare market is expected to boom amid increasing health awareness and technological advancements. Hence, we think fundamentally robust healthcare stocks Merck & Co. (MRK) and Elevance Health (ELV) could be solid investments now. Read…

StockNews.com

This Health Care Stock Is a No-Brainer Buy for Fall

Merck & Co.’s (MRK) third-quarter financials surpassed Wall Street’s expectations. The stock is trading near its 52-week high of $101.50, and its momentum is expected to continue, considering its strong fundamentals. Given the company’s solid growth, reliable dividend payments, and the resilience of its sector against the expected economic slowdown,…

StockNews.com

1 Medical Stock That's a Better Buy Than Its Peers

Healthcare giant (MRK) has gained more than 20% in 2022. Moreover, it pays handsome dividends to its shareholders. And its attractive valuations and robust profitability make it a better Buy than its peers. Let's discuss this in detail….

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Healthcare Stocks Under $100 to Buy Right Now

The rising prevalence of chronic diseases and the aging population are major growth drivers for the healthcare industry. In addition, increased investments in technological advancements should further bolster the industry’s growth. Thus, we think it may be prudent to buy quality healthcare stocks Pfizer Inc. (PFE), Merck & Co. (MRK),…

StockNews.com

Dogs of the Dow: 2 Stocks to Buy and 2 to Hold

The stock market has rebounded lately from the decline in the year's first half, thanks to better-than-expected corporate earnings and the expectation of easing inflationary pressure. However, a still uncomfortable inflation level and the possible aggressive rate hikes could keep the market volatile. The Dogs of the Dow investment strategy…

StockNews.com

4 "Strong Buy" Stocks for a Fear-Driven Market

Even though the inflation declined slightly from the 40-year high in July, it stayed elevated. Therefore, the Fed could maintain its hawkish stance on tightening monetary policy, which will drive market volatility. Amid this fear-driven market, we think it could be prudent to invest in fundamentally sound stocks AbbVie (ABBV),…

Benzinga

Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate

Here's a roundup of top developments in the biotech space over the last 24 hours:

StockNews.com

2 Stocks Hedge Funds Have Been Buying up in 2022

Amid the bear market, hedge funds have been buying shares of Merck & Co. (MRK) and Pfizer (PFE). This, along with the strong fundamentals and growth prospects of these stocks, makes them good additions to your watchlist. Let’s discuss.

StockNews.com

5 Highest Dividend-Paying Stocks in the Dow

The stock market has been under immense pressure owing to the growing concerns over a potential recession due to the tightening of monetary policy. Hence, we think it could be worth adding the Dow’s highest dividend-paying stocks, Goldman Sachs (GS), Merck (MRK), Coca-Cola Company (KO), Home Depot (HD), and McDonald's…

StockNews.com

4 Pharmaceutical Stocks with Tremendous Growth Potential

The global pharmaceutical industry has witnessed robust growth over the past few years. The rapidly aging population and continued breakthroughs in drug development are expected to keep driving the industry’s growth. Thus, we think pharmaceutical stocks Assertio Holdings (ASRT), Bayer (BAYRY), Eagle Pharmaceuticals (EGRX), and Merck (MRK), which possess solid…

1 2 3

People

Kritika SarmahHer

727 stories

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.